Product ID |
Product Name |
CAS# |
Purity |
Y3124918 |
2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]ethan-1-amine |
1008526-48-4 |
95% |
Y3235880 |
2,5-Bis(pyrid-4-yl)pyridine |
106047-32-9 |
97% |
Y3310164 |
3',5-Di-O-methyl quercetin |
40554-94-7 |
98% |
Y3308039 |
N-6-Methyl-2-deoxyadenosine-d3 |
1354782-02-7 |
99% |
Y3239833 |
N-((5-Chloropyrazin-2-yl)methyl)acetamidemin95% |
1956367-01-3 |
97% |
Y3246661 |
3-CHLORO-4-(2,6-DIMETHOXYPHENYL)CINNOLINE |
1956386-65-4 |
97% |
Y3123278 |
spiro[2.5]octane-4-carboxylic acid |
83115-72-4 |
95% |
Y3123310 |
1-amino-4,4-difluorocyclohexane-1-carboxylicacidhydrochloride |
1430854-20-8 |
95% |
Y3307902 |
6-Chloro-1H-indole-4-carbonitrile |
1097629-20-3 |
95% |
Y3306070 |
4-Benzyloxy-1H-indole-7-carboxylic aicd |
2173992-25-9 |
95% |
Y3310876 |
4-Chloro-5-nitro-1H-indole |
2600728-83-2 |
95% |
Y3312639 |
10-Chlorobenzo[b]naphtho[1,2-d]thiophene |
2085705-43-5 |
99% |
Y3247990 |
7-Chloro-5-phenylnaphtho[1,2-b]benzofuran |
2411141-58-5 |
98% |
Y3245935 |
(4'-Fluoro-[1,1'-biphenyl]-3-yl)boronic acid |
159020-61-8 |
95% |
Y3250392 |
Potassium [1,1'-biphenyl]-4-yltrifluoroborate |
705254-31-5 |
98% |
Y3246888 |
(E)-1,2-Bis(3-bromophenyl)ethene |
23958-26-1 |
97% |
Y3240624 |
trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)silane |
1208070-18-1 |
95% |
Y3296196 |
4-(4-Bromo-1H-pyrazol-1-yl)-3,3-difluoropiperidine |
1534350-68-9 |
95% |
Y3129147 |
tert-butyl(3R,5R)-3-fluoro-5-hydroxypiperidine-1-carboxylate |
2418594-22-4 |
95% |
Y3248955 |
2-(2-Cyclopropylethynyl)benzoic Acid |
1313028-09-9 |
98% |
Y3316673 |
2,4-Dibromo-6-methylpyrimidine |
2054922-16-4 |
95% |
Y3297850 |
(6-Chloropyridin-2-yl)(1-methylpiperidin-4-yl)methanone |
225112-16-3 |
95% |
Y3314691 |
N-[1,1′-Biphenyl]-4-yl-9,9′-spirobi[9H-fluoren]-4-amine |
1421789-18-5 |
98% |
Y3317677 |
N-[(2E)-1-Oxo-3-phenyl-2-propen-1-yl]glycine ethyl ester |
203116-76-1 |
95% |
Y3294205 |
Enavogliflozin |
1415472-28-4 |
98% |
Y3296467 |
Pyridine, 2-iodo-4-phenyl- |
945723-71-7 |
95% |
Y3289025 |
VPhos Pd G4 |
1848244-57-4 |
97% |
Y3286253 |
Cevidoplenib dimesylate |
2043659-93-2 |
98% |
Y3287431 |
2-(1-(2-(Trifluoromethyl)pyridin-4-yl)azetidin-3-yl)acetic acid |
2170724-09-9 |
95% |
Y3296664 |
5-amino-3-phenyl-4-cyano -1H pyrazole |
957046-71-8 |
95% |
Y3317064 |
2H-1-Benzopyran-2-carboxylic acid, 3,4-dihydro-7-(phenylmethoxy)- |
121175-61-9 |
95% |
Y3239953 |
N-(2-Oxopropyl)methanesulfonamide |
1496148-77-6 |
98% |
Y3295803 |
4-(6-chloro-5-nitropyridin-2-yl)-3,5-dimethylisoxazole |
2055852-91-8 |
95% |
Y3129179 |
5-(Difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic Acid |
1379794-41-8 |
95% |
Y1338617 |
2,5-Bis(2-methoxyethoxy)terephthalohydrazide |
2408841-97-2 |
95% |
Y3239761 |
(2-Amino-3,4,5,6-tetrafluorophenyl)boronic acid |
2657618-04-5 |
98% |
Y3129182 |
1-(2-bromoethyl)-3,3-difluoropyrrolidinehydrobromide |
2287283-91-2 |
95% |
Y3129184 |
2-(hydroxymethyl)oxan-4-one |
243968-13-0 |
95% |
Y3123770 |
rac-(1R,2S)-2-(trifluoromethyl)cyclopropan-1-aminehydrochloride |
1258640-83-3 |
95% |
Y1344502 |
4-AMINO-6-CHLORO-5-FLUORONICOTINAMIDE |
2454396-92-8 |
95% |
Y3123736 |
2-(7-methoxynaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
627526-31-2 |
95% |
Y1333576 |
OCTAHYDROCYCLOPENTA[C]PYRROL-5-OL HCL |
1417820-59-7 |
95% |
Y3309675 |
Cis-tert-Butyl ((2-hydroxycyclopentyl)methyl)carbamate |
2007174-31-2 |
95% |
Y3288159 |
SQ609 |
627052-25-9 |
97% |
Y3123116 |
JAK1-IN-8 |
1973485-18-5 |
95% |
Y3249931 |
2-Fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide hydrochloride |
2126164-56-3 |
98% |
Y3123423 |
5-bromo-3,4-dihydro-2H-1,4-benzoxazin-3-one |
1260672-39-6 |
95% |
Y3123237 |
5,7-dibromo-1,2,3,4-tetrahydroquinoline |
1997994-49-6 |
95% |
Y3241894 |
(3S)-7-bromo-2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylicacid |
281655-66-1 |
95% |
Y1338046 |
2,7-Dibromodibenzo[b,d]thiophene |
67001-77-8 |
97% |
Y3240731 |
3-Cyclopropyl-1H-pyrazol-4-amine hydrochloride |
2763779-46-8 |
97% |
Y3129156 |
methyl 1-hydroxypiperidine-2-carboxylate |
2624131-95-7 |
95% |
Y3317728 |
(2S)-2-Oxetanemethanamine tartrate |
2740593-21-7 |
98% |
Y3305810 |
4'-Bromo-2-chloro-biphenyl |
39802-88-5 |
98% |
Y3124927 |
Gliadin p31-43 |
176326-01-5 |
99% |
Y3225652 |
Mc-Gly-Gly-Phe-Gly-PAB-OH |
2632342-05-1 |
97% |
Y3292017 |
SDZ 224-015 |
161511-45-1 |
95% |
Y3287364 |
Rimtoregtide |
2251722-35-5 |
98% |
Y3124897 |
Oxytocin antiparallel dimer |
20054-93-7 |
98% |
Y3314028 |
1-(2,4-Bis(trifluoromethyl)phenyl)ethanol |
1265177-56-7 |
96% |
Y3124909 |
5-amino-2-oxo-1,2-dihydropyridine-3-carbonitrile |
1183402-93-8 |
93% |
Y3234200 |
3-(Difluoromethyl)-1H-pyrazol-4-amine |
1443288-79-6 |
95% |
Y3131584 |
1-cyclopropyl-1H-pyrazole-3-carbaldehyde |
1823349-88-7 |
95% |
Y3131600 |
ethyl 2,4-dichloro-6-(trifluoromethyl)pyridine-3-carboxylate |
1413281-75-0 |
95% |
Y3131575 |
methyl2-bromo-6-fluoro-4-(trifluoromethyl)benzoate |
2090520-15-1 |
95% |
Y3311758 |
4-Amino-3-fluoro-5-(trifluoromethyl)benzonitrile |
953091-29-7 |
95% |
Y3123756 |
2-(3-bromo-5-hydroxyphenyl)acetonitrile |
1261615-66-0 |
95% |
Y3313480 |
(2,4-dichloropyridin-3-yl)(phenyl)methanol |
134031-17-7 |
95% |
Y3123863 |
5,7-dimethoxy-2,4-dihydro-1H-3,1-benzoxazine-2,4-dione |
63920-75-2 |
95% |
Y3314046 |
4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-D-phenylalanine |
2512188-46-2 |
95% |
Y3130460 |
methyldivinylphosphine oxide |
945460-42-4 |
95% |
Y3234796 |
ethyl 5-amino-6-chloropyrimidine-4-carboxylate |
1393570-78-9 |
95% |
Y3130242 |
5-chloroquinoxalin-2-amine |
1379362-16-9 |
95% |
Y3309269 |
SYR127063(BDBM92454) |
871026-18-5 |
98% |
Y3130279 |
diethyl (2-(piperidin-4-yl)ethyl)phosphonate |
374776-33-7 |
95% |
Y3304536 |
3-(3-bromobenzyl)-4-methyl-4H-1,2,4-triazole |
1368533-94-1 |
95% |
Y3233934 |
1-(5-chloro-2-iodophenyl)ethan-1-one |
1685280-86-7 |
98% |
Y3123958 |
3-bromo-5-hydroxybenzenesulfonamide |
1243365-25-4 |
95% |
Y3313919 |
3-fluoro-5-(piperazin-1-yl)benzonitrile |
752967-51-4 |
95%+ |
Y3307845 |
SUVN-G3031 |
1394808-82-2 |
99% |
Y3316679 |
ethyl 1-(3-chlorobenzyl)-1H-indole-2-carboxylate |
220677-15-6 |
95%+ |
Y3123925 |
6-bromo-2,8-dimethylimidazo[1,2-b]pyridazine |
2361635-74-5 |
95% |
Y3286516 |
Alinidine HBr |
71306-36-0 |
99% |
Y3123922 |
1-(4-fluoro-2-methoxyphenyl)piperazine hydrochloride |
186386-96-9 |
95% |
Y3123931 |
(2R,3R,4S,5R,6R)-4,5-bis(acetyloxy)-6-(hydroxymethyl)-2-{[(2R,3R,4S,5R,6R)-3,4,5-tris(acetyloxy)-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-ylacetate |
67398-72-5 |
95% |
Y3316193 |
Pyrazolo[1,5-a]pyrimidin-7-ol, 2-methyl- |
1843260-69-4 |
95% |
Y3123112 |
5-(difluoromethyl)-4-methylpyridin-2-amine |
1805301-60-3 |
95% |
Y1335173 |
6-Bromo-4-chloro-2-cyclopropylquinazoline |
1697446-45-9 |
98% |
Y1335143 |
3,5-Diisopropylpyridin-4-amine |
1448615-55-1 |
95% |
Y1344274 |
RapiFluor-MS |
1429047-69-7 |
95% |
Y3286829 |
NV03 |
2448341-58-8 |
98% |
Y3288049 |
KRAS G12C inhibitor 14 |
2349393-95-7 |
98% |
Y3130464 |
4-(chloromethyl)-2,3-dihydro-1H-indene |
65898-31-9 |
95% |
Y1257766 |
1-(7-bromoquinoxalin-2-yl)ethanone |
1509899-17-5 |
96% |
Y1257837 |
(R)-methyl 2-hydroxypent-4-enoate |
96488-05-0 |
95% |
Y1249095 |
6-methyl-3-azabicyclo[4.1.0]hept-3-en-4-amine hydrochloride |
214479-63-7 |
95% |
Y1249096 |
tert-butyl 3-(naphthalen-2-yl)piperazine-1-carboxylate |
886770-80-5 |
95% |
Y3130561 |
N-[2-hydroxy-3-(2-methylphenoxy)propyl]-N-(2,4,6-trimethylphenyl)methanesulfonamide |
1040643-76-2 |
95% |
Y3130588 |
2-Thiopheneglyoxal hydrate |
1172227-73-4 |
95% |
Y3130378 |
3-Bromo-5-chloroisatoic anhydride |
122588-67-4 |
95% |